These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10191132)

  • 1. Ovine ceroid lipofuscinosis (OCL6): postulated mechanism of neurodegeneration.
    Jolly RD; Walkley SU
    Mol Genet Metab; 1999 Apr; 66(4):376-80. PubMed ID: 10191132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6).
    Oswald MJ; Palmer DN; Kay GW; Shemilt SJ; Rezaie P; Cooper JD
    Neurobiol Dis; 2005 Oct; 20(1):49-63. PubMed ID: 16137566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-specific pathology in neurons cultured from sheep affected with ceroid lipofuscinosis.
    Hughes SM; Kay GW; Jordan TW; Rickards GK; Palmer DN
    Mol Genet Metab; 1999 Apr; 66(4):381-6. PubMed ID: 10191133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease).
    Bronson RT; Lake BD; Cook S; Taylor S; Davisson MT
    Ann Neurol; 1993 Apr; 33(4):381-5. PubMed ID: 7683855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submitochondrial distribution and delayed proteolysis of subunit c of the H+-transporting ATP-synthase in ovine ceroid-lipofuscinosis.
    Hughes SM; Moroni-Rawson P; Jolly RD; Jordan TW
    Electrophoresis; 2001 May; 22(9):1785-94. PubMed ID: 11425233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specific loss of GnRH-positive neurons from the hypothalamus of sheep with CLN6 neuronal ceroid lipofuscinosis occurs without glial activation and has only minor effects on reproduction.
    Kay GW; Jay NP; Palmer DN
    Neurobiol Dis; 2011 Mar; 41(3):614-23. PubMed ID: 21111820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease).
    Jolly RD; Brown S; Das AM; Walkley SU
    Neurochem Int; 2002 May; 40(6):565-71. PubMed ID: 11850114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative biology of the neuronal ceroid-lipofuscinoses (NCL): an overview.
    Jolly RD
    Am J Med Genet; 1995 Jun; 57(2):307-11. PubMed ID: 7668352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP synthase activity in ovine ceroid lipofuscinosis [OCL6].
    Jolly RD; Bayliss SL; Das A; Cooke DG; Brown S
    Eur J Paediatr Neurol; 2001; 5 Suppl A():131-4. PubMed ID: 11588984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward positional cloning of ovine neuronal ceroid lipofuscinosis, a model of the human late-infantile variant CLN6.
    Broom MF; Zhou C; Hill DF
    Mol Genet Metab; 1999 Apr; 66(4):373-5. PubMed ID: 10191131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical studies in the ceroid-lipofuscinoses (Batten disease) using antibodies to subunit c of mitochondrial ATP synthase.
    Westlake VJ; Jolly RD; Bayliss SL; Palmer DN
    Am J Med Genet; 1995 Jun; 57(2):177-81. PubMed ID: 7668326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sheep and other animals with ceroid-lipofuscinoses: their relevance to Batten disease.
    Jolly RD; Martinus RD; Palmer DN
    Am J Med Genet; 1992 Feb; 42(4):609-14. PubMed ID: 1535180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalies of mitochondrial ATP synthase regulation in four different types of neuronal ceroid lipofuscinosis.
    Das AM; Jolly RD; Kohlschütter A
    Mol Genet Metab; 1999 Apr; 66(4):349-55. PubMed ID: 10191128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep.
    Pears MR; Salek RM; Palmer DN; Kay GW; Mortishire-Smith RJ; Griffin JL
    J Neurosci Res; 2007 Nov; 85(15):3494-504. PubMed ID: 17510975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression.
    Kay GW; Palmer DN
    J Neuroinflammation; 2013 Jul; 10():97. PubMed ID: 23899308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of brain dysfunction in Batten disease.
    Walkley SU; March PA; Schroeder CE; Wurzelmann S; Jolly RD
    Am J Med Genet; 1995 Jun; 57(2):196-203. PubMed ID: 7668330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue culture loading test with storage granules from animal models of neuronal ceroid-lipofuscinosis (Batten disease): testing their lysosomal degradability by normal and Batten cells.
    Elleder M; Drahota Z; Lisá V; Mares V; Mandys V; Müller J; Palmer DN
    Am J Med Genet; 1995 Jun; 57(2):213-21. PubMed ID: 7668332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant proteins in ovine ceroid-lipofuscinosis.
    Moroni-Rawson P; Palmer DN; Jolly RD; Jordan TW
    Am J Med Genet; 1995 Jun; 57(2):279-84. PubMed ID: 7668345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis.
    Kanninen KM; Grubman A; Meyerowitz J; Duncan C; Tan JL; Parker SJ; Crouch PJ; Paterson BM; Hickey JL; Donnelly PS; Volitakis I; Tammen I; Palmer DN; White AR
    PLoS One; 2013; 8(3):e58644. PubMed ID: 23516525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceroid-lipofuscinosis (Batten's disease): pathogenesis and sequential neuropathological changes in the ovine model.
    Jolly RD; Shimada A; Dopfmer I; Slack PM; Birtles MJ; Palmer DN
    Neuropathol Appl Neurobiol; 1989; 15(4):371-83. PubMed ID: 2779737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.